Dabrafenib vs Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer- Results of a Randomized, Phase 2, Open-Label, Multicenter Trial

Autor: Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas A. DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann-Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah
Rok vydání: 2022
Zdroj: SSRN Electronic Journal.
ISSN: 1556-5068
DOI: 10.2139/ssrn.4039920
Databáze: OpenAIRE